Academic entrepreneur Tony Marchington has teamed up with Leeds University to offer outsourced research and development in membrane biology to pharmaceutical, biotech and agrochemical companies. Dr Marchington, who turned his spin-off company Oxford Molecular into a business worth £450 million, will work alongside the university's new Centre for Integrative Membrane Biology to broker research contracts with industry. Membrane biology research is central to the improved treatment of human disease with pharmaceutical drugs.
Register to continue
Why register?
- Registration is free and only takes a moment
- Once registered, you can read 3 articles a month
- Sign up for our newsletter
Subscribe
Or subscribe for unlimited access to:
- Unlimited access to news, views, insights & reviews
- Digital editions
- Digital access to THE’s university and college rankings analysis
Already registered or a current subscriber?
Please or to read this article.